BioNTech (BNTX) News Today $96.31 -1.84 (-1.87%) Closing price 04:00 PM EasternExtended Trading$96.06 -0.25 (-0.26%) As of 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut4 hours ago | investors.comRep. Val T. Hoyle Sells BioNTech SE Sponsored ADR (NASDAQ:BNTX) StockSeptember 17 at 8:03 PM | marketbeat.com37,500 Shares in BioNTech SE Sponsored ADR $BNTX Purchased by Swedbank ABSeptember 17 at 3:45 AM | marketbeat.comLingohr Asset Management GmbH Lowers Stake in BioNTech SE Sponsored ADR $BNTXSeptember 16 at 5:48 AM | marketbeat.comBioNTech (NASDAQ:BNTX) Sees Large Volume Increase - Here's WhySeptember 14, 2025 | marketbeat.comBMO Capital Maintains a Buy on BioNTech SE (BNTX)September 14, 2025 | msn.comBioNTech (BNTX) Faces Legal Challenges Over mRNA PatentSeptember 13, 2025 | finance.yahoo.comWhy BioNTech Stock Sank by More Than 7% TodaySeptember 12, 2025 | fool.comBioNTech falls -9.8%September 12, 2025 | msn.comCOVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report saysSeptember 12, 2025 | marketwatch.comBioNTech SE Sponsored ADR $BNTX Shares Sold by Fred Alger Management LLCSeptember 11, 2025 | marketbeat.comBioNTech SE Sponsored ADR $BNTX Shares Purchased by Millennium Management LLCSeptember 11, 2025 | marketbeat.comBioNTech and DualityBio’s Phase 3 Trial Success in Breast CancerSeptember 11, 2025 | theglobeandmail.comBioNTech (NASDAQ:BNTX) Shares Down 6.5% - What's Next?September 10, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for BioNTech (NASDAQ:BNTX)September 10, 2025 | marketbeat.comAmundi Reduces Holdings in BioNTech SE Sponsored ADR $BNTXSeptember 10, 2025 | marketbeat.comBaird Financial Group Inc. Has $1.13 Million Holdings in BioNTech SE Sponsored ADR $BNTXSeptember 10, 2025 | marketbeat.comBioNTech (NASDAQ:BNTX) Receives Buy Rating from HC WainwrightSeptember 10, 2025 | americanbankingnews.comBioNTech and BMS Reveal Promising Phase 2 Results for Lung Cancer TreatmentSeptember 9, 2025 | msn.comWhat Analysts Are Saying About BioNTech StockSeptember 9, 2025 | benzinga.comBioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer ImmunotherapySeptember 8, 2025 | benzinga.comBioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trialSeptember 8, 2025 | reuters.comFirst Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor ActivitySeptember 8, 2025 | globenewswire.comPfizer, partner BioNTech say updated COVID shot shows better immune responseSeptember 8, 2025 | reuters.comBioNTech SE Sponsored ADR $BNTX Shares Acquired by Alyeska Investment Group L.P.September 8, 2025 | marketbeat.comEdmond DE Rothschild Holding S.A. Reduces Position in BioNTech SE Sponsored ADR $BNTXSeptember 7, 2025 | marketbeat.comBioNTech Surges 9% On Promising Test Results For Its Cancer Smart BombSeptember 6, 2025 | msn.comWhy Did BioNTech Stock Surge 10% Pre-Market Today?September 6, 2025 | msn.comBioNTech says trastuzumab pamirtecan met primary endpoint in Phase 3 trialSeptember 6, 2025 | msn.comBioNTech's First Oncology Win: A Major Step, But Not A Game-Changer YetSeptember 6, 2025 | seekingalpha.comBioNTech stock jumps after cancer drug meets primary endpoint in trialSeptember 5, 2025 | za.investing.comBioNTech Surges 10% On Promising Test Results For Its Cancer Smart BombSeptember 5, 2025 | investors.comBioNTech, Duality score initial trial win with breast cancer precision drugSeptember 5, 2025 | reuters.com31,021 Shares in BioNTech SE Sponsored ADR $BNTX Bought by Nomura Holdings Inc.September 5, 2025 | marketbeat.com5,000 Shares in BioNTech SE Sponsored ADR $BNTX Purchased by ADAR1 Capital Management LLCSeptember 4, 2025 | marketbeat.comRedmile Group LLC Sells 10,400 Shares of BioNTech SE Sponsored ADR $BNTXSeptember 4, 2025 | marketbeat.comCanada Pension Plan Investment Board Cuts Position in BioNTech SE Sponsored ADR $BNTXSeptember 4, 2025 | marketbeat.comPfizer responds to Trump’s criticism; to share data for new COVID shotSeptember 3, 2025 | msn.comLong Focus Capital Management LLC Sells 751,000 Shares of BioNTech SE Sponsored ADR $BNTXSeptember 1, 2025 | marketbeat.comBNP Paribas Financial Markets Has $108.86 Million Stake in BioNTech SE Sponsored ADR $BNTXSeptember 1, 2025 | marketbeat.comBioNTech SE Sponsored ADR $BNTX Shares Purchased by B. Metzler seel. Sohn & Co. AGSeptember 1, 2025 | marketbeat.comBioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Consensus Rating of "Moderate Buy" by AnalystsAugust 31, 2025 | marketbeat.comJump Financial LLC Invests $1.98 Million in BioNTech SE Sponsored ADR $BNTXAugust 30, 2025 | marketbeat.comAPG Asset Management N.V. Boosts Holdings in BioNTech SE Sponsored ADR $BNTXAugust 29, 2025 | marketbeat.comBioNTech SE Sponsored ADR $BNTX Shares Sold by Aristides Capital LLCAugust 28, 2025 | marketbeat.comAltrinsic Global Advisors LLC Sells 6,727 Shares of BioNTech SE Sponsored ADR $BNTXAugust 28, 2025 | marketbeat.comBioNTech SE Sponsored ADR $BNTX Shares Acquired by HighTower Advisors LLCAugust 28, 2025 | marketbeat.comPfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19August 27, 2025 | businesswire.comPfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19August 27, 2025 | globenewswire.comT. Rowe Price Investment Management Inc. Grows Stock Holdings in BioNTech SE Sponsored ADR $BNTXAugust 27, 2025 | marketbeat.com Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BNTX Media Mentions By Week BNTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼0.740.63▲Average Medical News Sentiment BNTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼1012▲BNTX Articles Average Week Get the Latest News and Ratings for BNTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BioNTech and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies GSK News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today Insmed News Today Teva Pharmaceutical Industries News Today Genmab A/S News Today Summit Therapeutics News Today Dr. Reddy's Laboratories News Today Ascendis Pharma A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNTX Stock Alerts